Faculty Opinions recommendation of Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study.
2021 ◽
Vol 5
(5)
◽
pp. 350-356
◽
2021 ◽
Keyword(s):
2018 ◽
Vol 104
(6)
◽
pp. 535-540
◽